Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Autor: Paavonen, Jorma, Jenkins, David, Bosch, F Xavier, Naud, Paulo, Salmerón, Jorge, Wheeler, Cosette M, Chow, Song-Nan, Apter, Dan L, Kitchener, Henry C, Castellsague, Xavier, de Carvalho, Newton S, Skinner, S Rachel, Harper, Diane M, Hedrick, James A, Jaisamrarn, Unnop, Limson, Genara AM, Dionne, Marc, Quint, Wim, Spiessens, Bart, Peeters, Pascal, Struyf, Frank, Wieting, Susan L, Lehtinen, Matti O, Dubin, Gary
Zdroj: In The Lancet 30 June-6 July 2007 369(9580):2161-2170
Databáze: ScienceDirect